1 Donati RJ, Thukral C, Rasenick MM.Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gsalpha[J].Mol Pharmacol, 2001;59(6):1426-32
2 Simbrey K, Winterhoff H, Butterweck V.Extracts of St.John's wort and various constituents affect β-adrenergic binding in rat frontal cortex[J].Life Sci, 2004;74(8):1027-38
3 Burgi S, Baltensperger K, Honegger UE.Antidepressant-induced switch of beta 1-adrenoceptor trafficking as a mechanism for drug action[J].J Biol Chem, 2003;278(2):1044-52
4 Zill P, Jager M, Rupprecht R, Moller HJ, Ackenheil M, Bondy B, et al.Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response[J]. Am J Med Genet, 2003;120B(1):85-9
5 Gonzalez-Maeso J, Rodriguez-Puertas R, Meana JJ, Garcia-Sevilla JA, Guimon J.Neurotransmitter receptor-mediated activation of G proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors[J]. Mol Psychiatry, 2002;7(7):755-67
6 Subhash MN, Nagaraja MR, Sharada S, Vinod KY.Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain[J].Neurochem Int, 2003;43(7):603-9
7 Rogoz Z, Margas W, Skuza G, Solich J, Kusmider M, Dziedzicka-Wasylewska M.Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors[J].Pol J Pharmacol, 2002;54(6):593-603
8 BourinM, David DJ, Jolliet P, Gardier A.Mechanism of action of antidepressants and therapeutic perspectives[J].Therapie, 2002;57(4):385-96
9 Van Oekelen D, Luyten WH, Leysen JE.5-HT2A and 5-HT2C receptors and their atypical regulation properties[J].Life Sci, 2003;72(22):2429-49
10 Dremencov E, Gispan-Herman I, Rosenstein M, Mendelman A, Overstreet DH, Zohar J, et al.The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment:in vivo studies in an animal model of depression[J]. Prog Neuro Psychopharmacol Biol Psychiatry, 2004;28(1): 141-7
11 Chini B, Parenti M.G protein coupled receptors in lipid rafts and caveolae:how, when and why do they go there[J].J Mol Endocrinol, 2004;32(2):325-38
12 Galeotti N, Bartolini A, Ghelardini C.Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forcedswimming test[J].Neuropharmacology, 2002;43(3):457-65
13 Alfonso J, Pollevick GD, Van Der Hart MG, Flugge G, Fuchs E, Frasch AC.Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocAMPus[J].Eur J Neurosci, 2004;19(3):659-66
14 Grange-Midroit M, Garcia-Sevilla JA, Ferrer-Alcon M, La Harpe R, Huguelet P, Guimon J.Regulation of GRK2 and 6, β-ARretin-2 and associated proteins in th prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression[J].Mol Brain Res, 2003;111(1-2):31-41
15 Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, et al.SSRIs antidepressant activity is influenced by Gβ3 variants[J].Eur Neuro Psychopharmacol, 2003;13(2): 117-22
16 Nagakura A, Niimura M, Takeo S.Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolisminduced defects in memory function and cerebral cyclic AMP signal transduction system in rats[J].Br J Pharmacol, 2002;135 (7):1783-93
17 Manier DH, Shelton RC, Sulser F.Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREBP[J].J Neural Transm, 2002;109(1):91-9
18 Li YF, Liu YQ, Luo ZP, Huang WC.Cytoprotective effect is one of common action pathways for antidepressants[J].Acta Pharmacol Sin, 2003;24(10):996-1000
19 Wolfgang WJ, Clay C, Parker J, Delgado R, Labarca P, Kidokoro Y.Sigaling through Gsalpha is required for the growth and function of neuromuscular synapses in Drosophila[J].Dev Biol, 2004;268(2):295-311
20 Budziszewska B, Jaworska-Feil L, Tetich M, Basta-Kaim A, Kubera M, Leskiewicz M, et al.Regulation of the human corticotropin-releasing-hormone gene promotor activity by antidepressant drugs in neuro-2A and AtT-20 cells[J].Neuro Psy chopharmacol, 2004;29(4):785-94 |
